Select Page

Second Opinion

Seen on public television stations across the country, the goal of Second Opinion is to promote good health, improve doctor/patient communication and empower viewers to take charge of their own healthcare, and in turn, help them navigate the medical system for better health outcomes.

New Host Joan Lunden

Second Opinion is proud to announce Joan Lunden as the new host.  

Joan Lunden

Second Opinion Welcomes Joan Lunden

Second Opinion with Joan Lunden is a national health initiative that reaches an engaged audience through television, web, social media, and community and national outreach. The series has been helping people become healthy, stay healthy, and navigate the healthcare system since its inception in 2004. Second Opinion with Joan Lunden uses the power and the mission of noncommercial public media to educate, promote good health, improve doctor/patient communication, and empower people to take charge of their own healthcare. Second Opinion with Joan Lunden focuses on health literacy in a way that is relevant and accessible to viewers and to physicians, in a format that engages and entertains. The program and related website and social media provide trusted health information on every platform, and the weekly television program engages viewers from across the United States as they watch doctors and patients talk through a variety of health issues from high blood pressure and cancer, to mental health and racial disparities in health.

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

It's ADHD Awareness Month. According to epidemiological data, approximately 5% of adults have ADHD. That represents over 11,000,000 people in the US. It occurs in both men and women and, in the majority of cases, persists throughout the lifespan. #ADHDAwarenessMonth (h/t Attention Deficit Disorder Association (ADDA)) ... See MoreSee Less

Its ADHD Awareness Month. According to epidemiological data, approximately 5% of adults have ADHD. That represents over 11,000,000 people in the US. It occurs in both men and women and, in the majority of cases, persists throughout the lifespan. #ADHDAwarenessMonth (h/t Attention Deficit Disorder Association (ADDA))

Join us for a live conversation between Joan Lunden and Dr. Beth Mittendorf about breast cancer research.

Dr. Beth Mittendorf is the Director of the Breast Immuno-Oncology Program at the Dana-Farber Cancer Institute and is an investigator with The Breast Cancer Research Foundation and we can't wait to speak with her. We hope you'll join us. #breastcancerawareness
... See MoreSee Less

Comment on Facebook

If anyone would like to read more about the TRIBUTE study, you can read a blog on our website about it: www.bcrf.org/blog/bcrf-s-new-tribute-study-uses-data-driven-approach-immunotherapy

Thank you Joan and Dr. Mittendorf for this great conversation!

Hello. I have question for the Doctor. I have T1bn0m0 TNBC. Had a lumpectomy and am currently doing ACT chemo and then followed by radiation. I have heard that chemo does not work for some. Is there anything else I can do to reduce the risk of reoccurrence? Any possibility of immunotherapy?

Hello Beth Naperville IL

Thank you, Joan and Beth, for having this conversation on Facebook Live.

Thank you! Loved it!

It seems like everyone is told they have "dense breast"!

View more comments

Load more

Support provided by

Become a Sponsor